Chemoinformaics analysis of CARNOSIC-ACID-12-METHYL-ETHER
| Molecular Weight | 348.439 | nRot | 2 |
| Heavy Atom Molecular Weight | 320.215 | nRig | 17 |
| Exact Molecular Weight | 348.194 | nRing | 3 |
| Solubility: LogS | -3.837 | nHRing | 0 |
| Solubility: LogP | 3.29 | No. of Aliphatic Rings | 2 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 53 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 1 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 6 |
| nHA | 4 | APOL | 56.0802 |
| nHD | 4 | BPOL | 28.9578 |
| QED | 0.609 |
| Synth | 4.142 |
| Natural Product Likeliness | 2.296 |
| NR-PPAR-gamma | 0.971 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.073 |
| HIA | 0.013 |
| CACO-2 | -5.009 |
| MDCK | 0.0000153 |
| BBB | 0.382 |
| PPB | 0.965647 |
| VDSS | 0.957 |
| FU | 0.0333902 |
| CYP1A2-inh | 0.025 |
| CYP1A2-sub | 0.537 |
| CYP2c19-inh | 0.012 |
| CYP2c19-sub | 0.848 |
| CYP2c9-inh | 0.135 |
| CYP2c9-sub | 0.869 |
| CYP2d6-inh | 0.007 |
| CYP2d6-sub | 0.187 |
| CYP3a4-inh | 0.029 |
| CYP3a4-sub | 0.139 |
| CL | 0.844 |
| T12 | 0.643 |
| hERG | 0.002 |
| Ames | 0.025 |
| ROA | 0.133 |
| SkinSen | 0.465 |
| Carcinogencity | 0.05 |
| EI | 0.738 |
| Respiratory | 0.641 |
| NR-Aromatase | 0.563 |
| Antiviral | No |
| Prediction | 0.691217 |